The present invention relates to : an activity modulatorwhich is a means for modulating the activity ofCD300b-dependent phagocytosis; and medicine for the treatment orprevention of a disease or condition in which the activity isinvolved. The activity modulator comprises a CD300a-bindingsubstance and modulates CD300b-dependent phagocytosis signalsin a macrophage.